Navigation Links
Medco Delivers First-Quarter 2009 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63; Reaffirms 2009 EPS Guidance; Announces Win of Coventry Commercial Business Starting January 1, 2010
Date:4/29/2009

7,605.2 7,097.5 Property and equipment, net 846.1 854.1 Goodwill 6,326.9 6,331.4 Intangible assets, net 2,651.9 2,666.4 Other noncurrent assets 56.1 61.5 ---- ---- Total assets $17,486.2 $17,010.9 ========= ========= LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Claims and other accounts payable $2,789.7 $2,878.9 Client rebates and guarantees payable 2,071.8 1,658.7 Accrued expenses and other current liabilities 717.2 660.4 Short-term debt 600.0 600.0 ----- ----- Total current liabilities 6,178.7 5,798.0 Long-term debt, net 4,001.2 4,002.9 Deferred tax liabilities 1,050.4 1,065.3 Other noncurrent liabilities 188.9 186.8 ----- ----- Total liabilities 11,419.2 11,053.0 Total stockholders' equity 6,067.0 5,957.9 ------- ------- Total liabilities and stockholders' equity $17,486.2 $17,010.9 ========= ========= March 28, December 27, 2009 2008 ---------- ------------ Balance Sheet Debt: ----
'/>"/>
SOURCE Medco Health Solutions, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23

Related biology technology :

1. Medco CEO to Shareholders: Delivering Results, Driving Shareholder Value
2. Medco to Present at the Deutsche Bank 33rd Annual Health Care Conference
3. Medco Issues $1.5 Billion of Senior Notes
4. Addressing the Pharmacist Shortage: Medco Labor Coalition(TM) Launches National Scholarship Program to Support the Development of the Next Generation of Pharmacists
5. Medco Chooses AllPoints at Anson in Whitestown, Indiana as Site for the Worlds Largest, Most-Advanced Automated Pharmacy
6. Medco to Webcast Annual Analyst Day Conference
7. Medco Announces Agreement to Acquire Diabetes Care Leader PolyMedica in Transaction Valued at $1.5 Billion
8. Santaris Pharma Delivers Six LNA-Based RNA Inhibitors to Enzon Pharmaceuticals Ahead of Schedule
9. Fat droplet nanoparticle delivers tumor suppressor gene to tumor and metastatic cells
10. Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion
11. ICON Delivers New Electronic Solution to Expedite Clinical Trial Adjudication
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... ON , July 11, 2014 /CNW/ - Sunovion ... approved APTIOM TM (eslicarbazepine acetate) for use as ... seizures in patients with epilepsy who are not satisfactorily ... indicated for use in patients under 18 years of ... most common neurological disorders and according to Epilepsy Canada, ...
(Date:7/10/2014)... 10, 2014 Deep Knowledge Ventures ... Forum on ‘Commercialising Longevity Research’ and welcomed a ... the London Bioscience Innovation Center for the event, ... Aging Analytics Ltd. The meeting highlighted the need ... research for age-related disease, as well as the ...
(Date:7/10/2014)... 2014 OMICS Group’s 5th International conference ... August, 2014 at Double Tree by Hilton Beijing, China ... in Analytical & Bioanalytical research methods only to facilitate ... this occasion, Dr. Srinubabu Gedela, MD of OMICS Group ... a remarkable one in bringing a unique and international ...
(Date:7/10/2014)... Capital, a firm specializing in acquiring and managing food ... the Slim-Fast brand from Unilever. Unilever will retain a ... were not disclosed. Slim-Fast is a branded ... shakes, powders, bars and snacks to retail customers throughout ... United Kingdom and Ireland.  The ...
Breaking Biology Technology:Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 2Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 3Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 4DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 2DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 3DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 4DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 5DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 6A Critical Review of Analytical Techniques for Improved Living Standards 2A Critical Review of Analytical Techniques for Improved Living Standards 3A Critical Review of Analytical Techniques for Improved Living Standards 4Kainos Capital Acquires Slim-Fast From Unilever 2
... June 21, 2011 Ikaria, Inc., a critical care ... to address the significant needs of critically ill patients ... its Chairman and CEO, Daniel Tasse, will present at ... International Convention on Tuesday, June 28, 2011 from 2:30 ...
... 2011 Merisel, Inc. (OTC: MSEL) operating under ... , a leading provider of visual communications and brand imaging ... last night at the 9th Annual American Business Awards Ceremony, ... its commitment to delivering solid results, despite prevailing economic turbulence. ...
... Halozyme Therapeutics, Inc. (Nasdaq: HALO ... targeting the extracellular matrix , today announced ... programs at the American Diabetes Association (ADA) ... 2011 at the San Diego Convention Center. ...
Cached Biology Technology:Ikaria® To Present at 2011 BIO Business Forum and International Convention 2Merisel, Inc. Wins Business Turnaround of the Year at the 2011 American Business Awards 2Merisel, Inc. Wins Business Turnaround of the Year at the 2011 American Business Awards 3Merisel, Inc. Wins Business Turnaround of the Year at the 2011 American Business Awards 4Merisel, Inc. Wins Business Turnaround of the Year at the 2011 American Business Awards 5Halozyme Therapeutics to Present Data on its Ultrafast Insulin Programs at the Upcoming American Diabetes Association 71st Scientific Sessions 2Halozyme Therapeutics to Present Data on its Ultrafast Insulin Programs at the Upcoming American Diabetes Association 71st Scientific Sessions 3
(Date:7/11/2014)... Janeiro, Brazil- In the brains of all vertebrates, ... allows an electric or chemical signal to be ... synapses, which are the most abundant type of ... formation is crucial for learning, memory, perception and ... synapses critical for brain function. For instance, ...
(Date:7/10/2014)... -- Aware, Inc. (NASDAQ: AWRE ), a leading ... June 26, 2014 that its Board of Directors had ... or approximately $40 million in total.  The Board established ... payment date of July 24, 2014.  The Company was ... ex-dividend date for this special cash dividend.  An ex-dividend ...
(Date:7/10/2014)... -- NXT-ID, Inc., (OTCQB: NXTD) a biometric authentication company focused on the ... was interviewed on July 1 st on the ... . Mr. Pereira discusses the company,s next generation smart wallet ... the Wocket™ aims to replace a traditional wallet with a ... tells Gino he has never heard of the Wocket ...
Breaking Biology News(10 mins):Blame it on the astrocytes 2NASDAQ Sets Ex-Dividend Date for Aware, Inc.'s Special Cash Dividend of $1.75 Per Share 2Security and Your Money: Tampa Bay Radio Host Cedric Harris Talks to NXT-ID CEO Mr. Gino Pereira about the Wocket Smart Wallet 2Security and Your Money: Tampa Bay Radio Host Cedric Harris Talks to NXT-ID CEO Mr. Gino Pereira about the Wocket Smart Wallet 3Security and Your Money: Tampa Bay Radio Host Cedric Harris Talks to NXT-ID CEO Mr. Gino Pereira about the Wocket Smart Wallet 4
... carried a gene that increases your risk for Alzheimer,s disease? And ... damage not when you,re old but when you,re young? ... strong genetic component to the development of late-onset Alzheimer,s. In 1993, ... a quarter of us that triples the risk for getting ...
... ARLINGTON, VA (May 3, 2011) Cancer studies from ... unveiled at the American Association of Pharmaceutical Scientists, (AAPS) ... May 16 -Wednesday, May 18 at the Hilton San ... Oral Vaccine for Cervical Cancer Cervical cancer ...
... overcome their evolutionary legacies to become much better at ... of energy that can power vehicles in the near ... solar scientists has found. A U.S. Department of ... 18 scientists to compare the efficiency of plants and ...
Cached Biology News:Alzheimer's risk gene disrupts brain's wiring 50 years before disease hits 2Alzheimer's risk gene disrupts brain's wiring 50 years before disease hits 3AAPS national biotechnology conference to highlight breakthrough cancer treatments 2NREL's multi-junction solar cells teach scientists how to turn plants into powerhouses 2NREL's multi-junction solar cells teach scientists how to turn plants into powerhouses 3
Molecular Biological Resources offers bulk quantities of existing protein products. Please see the Chimerx divisions website for existing products and contact lloconne@molbiores.com for pricing....
... scales with RS232 ports and sends that data ... type the weight into the program, BalanceTalk can ... use parser extracts required data , Add date/time ... Collect data at timed intervals , Keyboard macros ...
Peptide-affinity Purified Polyclonal Antibody to Prolactin Releasing Hormone Receptor (GPR10)...
... BalanceTalk XL provides balance data collection and automation ... Complete integration with Microsoft Excel , Pre-configured ... analyzers , New balances can be added and ... data from multiple balances into one spreadsheet ...
Biology Products: